mSaada: A Mobile Health Tool to Improve Cervical Cancer Screening in western Kenya
mSaada:改善肯尼亚西部宫颈癌筛查的移动健康工具
基本信息
- 批准号:10688110
- 负责人:
- 金额:$ 16.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-22 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptedAfrica South of the SaharaCancer BurdenCancer ControlCase ManagementCellular PhoneCervical Cancer ScreeningClinicClinicalCluster randomized trialCollaborationsCommunitiesCommunity HealthComputerized Medical RecordCounselingCountryDataData CollectionDecision MakingDevelopmentEducation and OutreachEffectivenessElectronicsEligibility DeterminationEnsureFocus GroupsFutureGuidelinesHealthHealth care facilityHealth systemHealthcareHuman Papilloma Virus VaccinationHuman Papilloma Virus-Related Malignant NeoplasmHuman PapillomavirusHuman ResourcesIndividualInformation ManagementInfrastructureInternationalInterventionInterviewKenyaKnowledgeLaboratoriesMalignant NeoplasmsMalignant neoplasm of cervix uteriMeasuresModelingMorbidity - disease ratePatient EducationPatientsPerformancePhasePilot ProjectsPlayPreventionPrevention programPrevention strategyProcessProgram EffectivenessProgram EvaluationProtocols documentationProviderRecommendationResearchResearch DesignResource-limited settingRoleSamplingServicesSpecimenSurveysSystemTechnologyTest ResultTestingTime and Motion StudiesTrainingUnderserved PopulationUnited StatesVaccinationWomanWorkWorld Health Organizationacceptability and feasibilityage groupagedarmcancer riskcervical cancer preventioncostdesigndigitaldigital healthdigital platformeffectiveness clinical trialeffectiveness evaluationeffectiveness trialeffectiveness/implementation designeffectiveness/implementation studyevidence baseexperiencefallsfollow-upimplementation determinantsimplementation facilitatorsimplementation strategyimprovedinnovationlow and middle-income countriesmHealthmobile applicationmortalityopen sourcepreventprevention serviceprogramsprototyperandomized, clinical trialsrecruitreproductiverisk perceptionscale upscreeningscreening programtooluptakeusabilityvolunteer
项目摘要
Abstract
Cervical cancer is the most common cancer among women in many low- and middle-income countries,
including Kenya. This is mainly due to the lack of screening, which remains the cornerstone of prevention for
the over one hundred million reproductive-aged women who fall outside the target age group or live in
countries where the human papillomavirus (HPV) vaccination is not available. While HPV-based screening has
the potential to be incorporated into simplified protocols, the laboratory testing component requires programs to
have capacity to track specimens, results and patient follow-up, which can be a challenge in settings with
limited healthcare infrastructure and no electronic medical records. Further, low baseline knowledge of HPV
and cervical cancer risk in the community is associated with low rates of screening and follow-up, making
effective outreach and education a key component of screening programs. This work is often done by
community health volunteers (CHVs) with limited content-specific training. We propose to fill these gaps
through an integrated digital platform that includes a mobile app (mSaada) that supports CHVs with patient and
specimen tracking and follow-up, and counseling and protocol support. In the R21 phase of this project, we will:
(1) work with key stakeholders and local and international developers to finalize the mSaada platform, building
on the existing prototype to add patient and specimen tracking functionality; and (2) carry out a pilot study to
identify the patient, provider and health system factors necessary to design a trial to evaluate mSaada
effectiveness and implementation factors. We will carry out a six-month pilot in two health facilities providing
HPV-based screening, and use performance metrics including system usage rates, workflow observations and
qualitative data to guide the planning of a cluster-randomized clinical trial (c-RCT) to determine effectiveness of
mSaada. In the R33 phase of the project, we will use a hybrid implementation effectiveness design to: (1)
conduct an 18-month c-RCT across 12 health facilities to determine the impact of mSaada on cervical cancer
screening uptake, treatment acquisition and cervical cancer knowledge levels among women in the community;
and (2) measure the requisite implementation factors for mSaada effectiveness, sustainability, and scale-up.
The rigorous study design will allow us to determine the clinical impact of mSaada, ensure the local and
regional infrastructure has the capacity necessary for sustainability and develop strategies for widespread
implementation and scale-up. Collaboration with key stakeholders from the Kenya Ministry of Health will
facilitate the development of a long-term sustainability plan as the country moves toward HPV-based cervical
cancer screening. We anticipate the mSaada platform will play a pivotal role in facilitating the introduction of
HPV-based screening programs that can reach women in settings with limited health care infrastructure.
抽象的
宫颈癌是许多低收入和中等收入国家中女性中最常见的癌症,
包括肯尼亚。这主要是由于缺乏筛查,这仍然是预防的基石
属于目标年龄段或居住在目标年龄段之外的一亿多百万生殖妇女
没有人乳头瘤病毒(HPV)疫苗接种的国家。而基于HPV的筛选具有
将其合并到简化协议中的潜力,实验室测试组件需要程序才能
具有跟踪标本,结果和患者随访的能力,这可能是与
有限的医疗基础设施,没有电子病历。此外,HPV的基线知识低
社区中的宫颈癌风险与筛查和随访率低有关,使得
有效的外展和教育是筛查计划的关键组成部分。这项工作通常是由
社区卫生志愿者(CHVS)进行了有限的特定内容培训。我们建议填补这些空白
通过一个包括移动应用程序(MSAADA)的集成数字平台,该应用程序支持患者的CHV和
标本跟踪和随访以及咨询和协议支持。在该项目的R21阶段,我们将:
(1)与主要利益相关者以及本地和国际开发商合作,最终确定MSAADA平台,建造
在现有的原型上添加患者和标本跟踪功能; (2)进行试点研究
确定设计试验以评估MSAADA所需的患者,提供者和卫生系统因素
有效性和实施因素。我们将在两个提供的医疗机构中进行六个月的飞行员
基于HPV的筛选,并使用性能指标,包括系统使用率,工作流观测和
定性数据指导群集随机临床试验(C-RCT)的计划以确定有效性
MSAADA。在项目的R33阶段,我们将使用混合实施有效性设计:(1)
在12个医疗机构中进行18个月的C-RCT,以确定MSAADA对宫颈癌的影响
筛选社区女性的摄取,治疗获取和宫颈癌知识水平;
(2)衡量MSAADA有效性,可持续性和扩大规模的必要实施因素。
严格的研究设计将使我们能够确定MSAADA的临床影响,确保本地和
区域基础设施具有可持续性必要的能力,并制定了广泛的策略
实施和扩展。与肯尼亚卫生部的主要利益相关者合作将
随着该国朝着基于HPV的宫颈的发展,促进长期可持续性计划的制定
癌症筛查。我们预计MSAADA平台将在促进引入
基于HPV的筛查计划,可以在医疗保健基础设施有限的环境中吸引妇女。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Megan J. Huchko其他文献
Rectus sheath hematoma after transvaginal follicle aspiration: A rare complication of in vitro fertilization
- DOI:
10.1016/j.fertnstert.2005.01.116 - 发表时间:
2005-07-01 - 期刊:
- 影响因子:
- 作者:
Jeff G. Wang;Megan J. Huchko;Suzanne Kavic;Mark V. Sauer - 通讯作者:
Mark V. Sauer
Megan J. Huchko的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Megan J. Huchko', 18)}}的其他基金
A stigma responsive service delivery model for HPV-based screening among women living with HIV
针对感染艾滋病毒的女性进行基于 HPV 筛查的耻辱响应服务提供模式
- 批准号:
10669752 - 财政年份:2022
- 资助金额:
$ 16.07万 - 项目类别:
mSaada: A Mobile Health Tool to Improve Cervical Cancer Screening in western Kenya
mSaada:改善肯尼亚西部宫颈癌筛查的移动健康工具
- 批准号:
10525538 - 财政年份:2022
- 资助金额:
$ 16.07万 - 项目类别:
Development and Validation of an Artificial-Intelligence-enabled Portable Colposcopy Device for Optimizing Triage Alternatives for HPV-based Cervical Cancer Screening
开发和验证人工智能便携式阴道镜设备,用于优化基于 HPV 的宫颈癌筛查的分诊方案
- 批准号:
10625379 - 财政年份:2022
- 资助金额:
$ 16.07万 - 项目类别:
A stigma responsive service delivery model for HPV-based screening among women living with HIV
针对感染艾滋病毒的女性进行基于 HPV 筛查的耻辱响应服务提供模式
- 批准号:
10542876 - 财政年份:2022
- 资助金额:
$ 16.07万 - 项目类别:
Developing a tool to measure cervical cancer stigma among HIV+ women in Kenya
开发一种工具来衡量肯尼亚艾滋病毒妇女中宫颈癌的耻辱感
- 批准号:
9753601 - 财政年份:2019
- 资助金额:
$ 16.07万 - 项目类别:
Developing a tool to measure cervical cancer stigma among HIV+ women in Kenya
开发一种工具来衡量肯尼亚艾滋病毒妇女中宫颈癌的耻辱感
- 批准号:
9914142 - 财政年份:2019
- 资助金额:
$ 16.07万 - 项目类别:
Evaluating a community-driven cervical cancer prevention model in western Kenya
评估肯尼亚西部社区驱动的宫颈癌预防模式
- 批准号:
8762661 - 财政年份:2014
- 资助金额:
$ 16.07万 - 项目类别:
Evaluating a community-driven cervical cancer prevention model in western Kenya
评估肯尼亚西部社区驱动的宫颈癌预防模式
- 批准号:
8930102 - 财政年份:2014
- 资助金额:
$ 16.07万 - 项目类别:
Evaluating a community-driven cervical cancer prevention model in western Kenya
评估肯尼亚西部社区驱动的宫颈癌预防模式
- 批准号:
9126481 - 财政年份:2014
- 资助金额:
$ 16.07万 - 项目类别:
Evaluating a community-driven cervical cancer prevention model in western Kenya
评估肯尼亚西部社区驱动的宫颈癌预防模式
- 批准号:
9344547 - 财政年份:2014
- 资助金额:
$ 16.07万 - 项目类别:
相似国自然基金
采用新型视觉-电刺激配对范式长期、特异性改变成年期动物视觉系统功能可塑性
- 批准号:32371047
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
破解老年人数字鸿沟:老年人采用数字技术的决策过程、客观障碍和应对策略
- 批准号:72303205
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
通过抑制流体运动和采用双能谱方法来改进烧蚀速率测量的研究
- 批准号:12305261
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
采用多种稀疏自注意力机制的Transformer隧道衬砌裂缝检测方法研究
- 批准号:62301339
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
政策激励、信息传递与农户屋顶光伏技术采用提升机制研究
- 批准号:72304103
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Adapting and Piloting an Evidence-based Intervention to Improve Hypertension Care among Tanzanians Living with HIV
调整和试点循证干预措施以改善坦桑尼亚艾滋病毒感染者的高血压护理
- 批准号:
10750666 - 财政年份:2023
- 资助金额:
$ 16.07万 - 项目类别:
Developing a regionally representative risk assessment tool to identify men at highest risk of HIV acquisition in sub-Saharan Africa
开发具有区域代表性的风险评估工具,以确定撒哈拉以南非洲地区感染艾滋病毒风险最高的男性
- 批准号:
10762645 - 财政年份:2023
- 资助金额:
$ 16.07万 - 项目类别:
Investigating the impact of preference-concordant differentiated service delivery for HIV
调查偏好一致的差异化服务提供对艾滋病毒的影响
- 批准号:
10619804 - 财政年份:2023
- 资助金额:
$ 16.07万 - 项目类别:
An interactive, narrative intervention to address the mental health treatment gap among young people living with HIV in Nigeria
一种互动式叙事干预措施,旨在解决尼日利亚艾滋病毒感染者年轻人的心理健康治疗差距
- 批准号:
10914342 - 财政年份:2023
- 资助金额:
$ 16.07万 - 项目类别:
Enhanced Cervical Cancer Screening Adoption and Treatment Linkage for HIV positive Women in Kenya (eCASCADE-Kenya)
加强肯尼亚艾滋病毒阳性女性的宫颈癌筛查采用和治疗联系 (eCASCADE-Kenya)
- 批准号:
10738134 - 财政年份:2023
- 资助金额:
$ 16.07万 - 项目类别: